The global prothrombin complex concentrate (PCC) market size was valued at USD 695.3 million in 2019 and is projected to reach USD 2,385.3 million by 2032, exhibiting a CAGR of 9.6% during the forecast period (2019-2032). North America dominated the prothrombin complex concentrate market with a market share of 44.% in 2019.